Valeo Financial Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Valeo Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$8.71 - $10.72 $3,109 - $3,827	-357 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$12.89 - $15.89 $876 - $1,080	-68 Reduced 16.0%	357 $5,000
Q2 2020 Jul 20, 2020	BUY	$8.86 - $15.69 $3,163 - $5,601	357 Added 525.0%	425 $6,000
Q1 2020 Apr 13, 2020	SELL	$6.63 - $11.16 $1,538 - $2,589	-232 Reduced 77.33%	68 $1,000
Q4 2019 Jan 24, 2020	BUY	$7.48 - $10.75 $2,244 - $3,225	300 New	300 $3,000
Q3 2019 Oct 15, 2019	SELL	$8.02 - $13.25 $2,406 - $3,975	-300 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$10.96 - $14.4 $3,288 - $4,320	300 New	300 $4,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.73B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.